The results appear March 4 in The BMJ
Not intended for human consumption, clinical diagnosis, or therapeutic application
Stop eating when you feel satisfied (not full)your "full" signals will be much stronger than before
Retatrutide: Eli Lillys Triple-Agonist Weight Loss Injection Explained (May 2026 Update) Eli Lillys latest development, Retatrutide , is showing extraordinary potential as a groundbreaking treatment for obesity and metabolic health
Currently approved weight management pharmacotherapy in the UK includes: Semaglutide (Wegovy) a GLP-1 receptor agonist approved by the MHRA for chronic weight management in adults, subject to NICE Technology Appraisal eligibility criteria [3] [5] Tirzepatide (Mounjaro) a dual GIP/GLP-1 receptor agonist approved by the MHRA for the treatment of type 2 diabetes
PLAN ONE: MEDICATION + SUPPORT PLAN TWO: PRESCRIPTION + SUPPORT Regardless of your path, if youre interested in GLP-1 weight loss or need a new GLP-1 partner, WE CAN HELP
